| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/12/2000 | EP1018517A2 Binding agents to CD23 for treatment of inflammatory, autoimmune or allergic diseases |
| 07/12/2000 | EP1018513A2 Quinolinecarboxylic acid derivatives |
| 07/12/2000 | EP1018512A1 Novel basic derivatives of benz(e)isoindol-1-ones and pyrrolo(3,4-c)quinolin-1-ones with 5-HT3-antagonistic activity, their preparation and their therapeutic use |
| 07/12/2000 | EP1018506A1 Substituted alkyltetramine derivatives |
| 07/12/2000 | EP1017713A1 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 07/12/2000 | EP1017711A2 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action |
| 07/12/2000 | EP1017693A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them |
| 07/12/2000 | EP1017673A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents |
| 07/12/2000 | EP1017667A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 07/12/2000 | EP1017423A1 Cloning pigs using donor nuclei from differentiated cells |
| 07/12/2000 | EP1017418A1 Vaccine composition for preventing or treating c hepatitis |
| 07/12/2000 | EP1017412A1 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease |
| 07/12/2000 | EP1017404A1 Pharmaceutical composition for the treatment of inflammatory bowel disease |
| 07/12/2000 | EP1017403A1 Use of zinc hyaluronate against peptic ulcer |
| 07/12/2000 | EP1017402A1 Control of acidic gut syndrome |
| 07/12/2000 | EP1017397A1 Photosensitizer conjugates for pathogen targeting |
| 07/12/2000 | EP1017385A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/12/2000 | EP1017382A1 Biarylalkanoic acids as cell adhesion inhibitors |
| 07/12/2000 | EP1017378A1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 07/12/2000 | EP1017377A2 Use of 6, 7-substituted 2-aminotetralines for the treatment of cytokine mediated inflammatory conditions |
| 07/12/2000 | EP0934071A4 Non-aqueous colonic purgative formulations |
| 07/12/2000 | EP0613468B1 Substituted salicylic acids for the treatment of autoimmune diseases |
| 07/12/2000 | CN1260000A Recombination proteins of Pakistani strain of hepatitis E and their use in diagnostic method and vaccines |
| 07/12/2000 | CN1259958A Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 07/12/2000 | CN1259948A 6,7-disubstituted-4-aminopyrido [2,3-D] pyrimidine compounds |
| 07/12/2000 | CN1259940A Crystalline roxifiban |
| 07/12/2000 | CN1259874A Vaginal lactobacillus medicant |
| 07/12/2000 | CN1259873A Bio-pharmaceutical prepn. contg. live culture of bacillus and method treating viral and bacterial infection as well as immuno-deficiency conditions |
| 07/12/2000 | CN1259863A Therapeutically active compositions |
| 07/12/2000 | CN1259570A Mortierella Diding, its isolation cultivation method and fermentation technology |
| 07/12/2000 | CN1259371A Medicinal drops for treating dental caries |
| 07/12/2000 | CN1259368A Medicine for treating gastritis, gastric ulcer and duodenal ulcer and its prepn. method |
| 07/12/2000 | CN1259366A Traditional Chinese medicinal pill benefiting kidney and primordial energy |
| 07/12/2000 | CN1259364A Medicinal composition for treating stomach and intestine ulcer |
| 07/12/2000 | CN1259346A Optically pure compound as medicinal use |
| 07/12/2000 | CN1054377C New bicyclic derivatives of imidazole and their prepn. process, their use as medicaments and the pharmaceutical compositions containing them |
| 07/12/2000 | CN1054374C New (thia) cycloalkyl [b] indole compounds process for the prepn. thereof and pharmaceutical compositions containing them |
| 07/12/2000 | CN1054298C Medicine for treating gastropathy and esophagus cancer |
| 07/12/2000 | CN1054296C Medicine powder for hepatitis B, and its prepn. method |
| 07/11/2000 | US6087505 Benzo[1,2-G]-chrom-3-ene, and benzo[1,2-G]-thiochrom-3-ene derivatives |
| 07/11/2000 | US6087392 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 07/11/2000 | US6087381 Pyrazole derivatives as p38 kinase inhibitors |
| 07/11/2000 | US6087377 Reducing the side effects associated with anticancer drug irinotecan by administering an antiestrogen at least two cell cycles prior to administration of the irinotecan |
| 07/11/2000 | US6087368 Quinazolinone inhibitors of cGMP phosphodiesterase |
| 07/11/2000 | US6087357 Piperazine derivatives as tachykinin antagonists |
| 07/11/2000 | US6087334 Anti-diabetic peptides |
| 07/11/2000 | US6087167 Promoting neuron survival or neurite outgrowth by contacting neurons with an amount of an eck receptor binding protein of specific amino acid sequence |
| 07/11/2000 | US6086374 Methods of treatment using bioactive glass |
| 07/11/2000 | CA2023340C (quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes |
| 07/06/2000 | WO2000039311A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 07/06/2000 | WO2000039285A2 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof |
| 07/06/2000 | WO2000039283A1 Use of cd40 engagement to alter t cell receptor usage |
| 07/06/2000 | WO2000039279A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | WO2000039249A1 Ume extract having medicinal effects and compositions containing the same |
| 07/06/2000 | WO2000039176A1 Hydrophilic ampholytic polymer |
| 07/06/2000 | WO2000039160A2 Caspase-8 interacting proteins |
| 07/06/2000 | WO2000039136A2 Human brainiac-5 |
| 07/06/2000 | WO2000039126A1 Method for preparing (r)- (+) -3 {1- [2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates |
| 07/06/2000 | WO2000039123A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues |
| 07/06/2000 | WO2000039120A2 Compounds and methods for modulation of estrogen receptors |
| 07/06/2000 | WO2000039116A1 Aminopyrazole derivatives |
| 07/06/2000 | WO2000039114A2 Substituted oximes and hydrazones as neurokinin antagonists |
| 07/06/2000 | WO2000039096A1 2-methylimidazoline compounds |
| 07/06/2000 | WO2000039091A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/06/2000 | WO2000039089A1 3-azabicyclo[3.1.0.] hexane derivatives as opiate receptors ligands |
| 07/06/2000 | WO2000039088A1 Glucagon antagonists/inverse agonists |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038729A1 Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038701A1 Use of unsaponifiable matters of vegetable oils for preparing a medicine |
| 07/06/2000 | WO2000038687A1 Protease inhibitors |
| 07/06/2000 | WO2000038684A1 (2-imidazolin-2-ylamino) quinoxaline derivatives for the treatment of pain |
| 07/06/2000 | WO2000038676A1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 07/06/2000 | WO2000038674A1 COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038660A2 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | WO2000038653A1 Improved formulation for topical non-invasive application in vivo |
| 07/06/2000 | WO2000038643A1 Oral hygiene product containing spherical microparticles on the basis of linear water-insoluble polyglucans |
| 07/06/2000 | WO2000038537A1 α-AMYLASE-RESISTANT STARCH FOR PRODUCING FOODSTUFF AND MEDICAMENTS |
| 07/06/2000 | WO2000038536A2 Inhibitors of the bitter taste response |
| 07/06/2000 | WO2000038535A1 Food-induced antisecretory proteins in egg yolk |
| 07/06/2000 | WO2000020591A3 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 07/06/2000 | WO2000018352A3 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/06/2000 | WO2000017222A8 31 human secreted proteins |
| 07/06/2000 | WO2000015770A3 Human serine/threonine protein kinases |
| 07/06/2000 | WO2000014222A3 Gabab receptor subtypes gabab-r1c and gabab-r2 and heterodimers thereof |
| 07/06/2000 | WO2000011028A3 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 07/06/2000 | WO1999052514A3 Pharmaceutical composition and combination preparation for immunosuppressive therapy |
| 07/06/2000 | WO1999041282A8 Therapeutic uses of keratinocyte growth factor-2 |
| 07/06/2000 | DE19860375A1 Alpha Amylase-resistente Stärke zur Herstellung von Nahrungs- und Arzneimittel Alpha amylase-resistant starch for the production of food and drugs |
| 07/06/2000 | DE19860373A1 Mundpflegemittel enthaltend shärische Mikropartikel auf Basis linearer wasserunlöslicher Polyglucane Oral care compositions comprising shärische microparticles based on linear water-insoluble polyglucans |
| 07/06/2000 | CA2358687A1 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2358094A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 07/06/2000 | CA2358067A1 (2-imidazolin-2-ylamino) quinoxaline derivatives for the treatment of pain |